1. Zhang, Jinjin, Wang, Haixia, Chen, Hongbin, Lv, Changjun, Song, Xiaodong. 2022. ATF3 -activated accelerating effect of LINC00941/lncIAPF on fibroblast-to-myofibroblast differentiation by blocking autophagy depending on ELAVL1/HuR in pulmonary fibrosis. In Autophagy, 18, 2636-2655. doi:10.1080/15548627.2022.2046448. https://pubmed.ncbi.nlm.nih.gov/35427207/
2. Kuniyoshi, Kazuki, Hayashi, Takaaki, Kameya, Shuhei, Nakano, Tadashi, Kusaka, Shunji. 2020. Clinical Course and Electron Microscopic Findings in Lymphocytes of Patients with DRAM2-Associated Retinopathy. In International journal of molecular sciences, 21, . doi:10.3390/ijms21041331. https://pubmed.ncbi.nlm.nih.gov/32079136/
3. Wudu, Muli, Ren, Hongjiu, Hui, Linping, Dao, Runa, Qiu, Xueshan. 2019. DRAM2 acts as an oncogene in non-small cell lung cancer and suppresses the expression of p53. In Journal of experimental & clinical cancer research : CR, 38, 72. doi:10.1186/s13046-019-1068-4. https://pubmed.ncbi.nlm.nih.gov/30755245/
4. Azhati, Baihetiya, Maolakuerban, Naibijiang, Ma, Tao, Li, Xiaodong, Rexiati, Mulati. 2020. Up-regulation of DRAM2 promotes tolerance of bladder transitional cell carcinoma to gemcitabine. In Archives of medical science : AMS, 16, 1207-1217. doi:10.5114/aoms.2020.93748. https://pubmed.ncbi.nlm.nih.gov/32864010/
5. El-Asrag, Mohammed E, Sergouniotis, Panagiotis I, McKibbin, Martin, Toomes, Carmel, Ali, Manir. 2015. Biallelic mutations in the autophagy regulator DRAM2 cause retinal dystrophy with early macular involvement. In American journal of human genetics, 96, 948-54. doi:10.1016/j.ajhg.2015.04.006. https://pubmed.ncbi.nlm.nih.gov/25983245/